What Has Been the Progress and Growth of the Antipsychotic Drugs Market in Recent Years?
The antipsychotic drugs market has seen considerable growth due to a variety of factors.
• The antipsychotic drugs market has experienced rapid growth in recent years. It is projected to increase from $19.5 billion in 2024 to $21.45 billion in 2025, at a compound annual growth rate (CAGR) of 10.0%.
Factors contributing to this growth include the rising prevalence of mental health disorders, the development of second-generation antipsychotics, the aging population, improvements in healthcare infrastructure, and higher investments in research and development.
How Does the Forecast Look for the Antipsychotic Drugs Market?
The antipsychotic drugs market is expected to maintain its strong growth trajectory in upcoming years.
• The antipsychotic drugs market is expected to expand significantly, reaching $31.04 billion by 2029 with a CAGR of 9.7%.
This growth is attributed to the increasing cases of schizophrenia and bipolar disorder, supportive government policies, rising demand for personalized medicine, focus on reducing side effects, and growing mental health awareness. Key trends include the use of digital health tools for monitoring, novel mechanisms of action, combination therapies, pharmacogenomics for tailored treatments, and a patient-centered drug development approach.
What Are The Leading Drivers Of Growth In The Antipsychotic Drugs Market?
The growing incidence of mental disorders is expected to propel the growth of the antipsychotic drug market. Mental disorders, which impact thinking, behavior, and mood, are on the rise due to various factors such as stress, societal pressures, and genetic predisposition. Antipsychotic drugs help control symptoms of mental disorders by affecting neurotransmitters in the brain. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), about 6% of adults in the US experience serious mental illness, driving the demand for antipsychotic drugs.
How Are The Segments Defined Within The Global Antipsychotic Drugs Market?
The antipsychotic drugs market covered in this report is segmented –
1) By Therapeutic Class: First Generation, Second Generation, Third Generation
2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines
2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone
3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine
Pre-Book The Antipsychotic Drugs Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Antipsychotic Drugs Market?
In the antipsychotic drug market, companies are innovating with subcutaneous atypical antipsychotic injections to improve patient compliance. For instance, in April 2023, Teva Pharmaceutical Industries and MedinCell launched UZEDY, an extended-release injectable formulation of risperidone. UZEDY provides flexible dosing intervals and demonstrated a significant reduction in the risk of schizophrenia relapse compared to placebo. It offers a solution to the adherence issues commonly seen with oral antipsychotics.
Who Are the Key Players In The Antipsychotic Drugs Market?
Major companies operating in the antipsychotic drugs market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck And Co. Inc.
• AbbVie Inc.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly And Company
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Aurobindo Pharma Ltd.
• Cipla Ltd.
• H. Lundbeck A/S
• Dr. Reddy’s Laboratories Ltd.
• Intas Pharmaceuticals Ltd.
• Apotex Inc.
• Lupin Limited
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• Alkermes plc
What Is The Most Dominant Region In The Antipsychotic Drugs Market?
North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
